113 related articles for article (PubMed ID: 10774633)
1. An improved gas chromatography assay for topiramate monitoring in pediatric patients.
Tang PH; Miles MV; Glauser TA; Coletta L; Doughman N; Doose D; Frey M; DeGrauw A
Ther Drug Monit; 2000 Apr; 22(2):195-201. PubMed ID: 10774633
[TBL] [Abstract][Full Text] [Related]
2. A capillary gas chromatographic assay with nitrogen phosphorus detection for the quantification of topiramate in human plasma, urine and whole blood.
Riffitts JM; Gisclon LG; Stubbs RJ; Palmer ME
J Pharm Biomed Anal; 1999 Mar; 19(3-4):363-71. PubMed ID: 10704102
[TBL] [Abstract][Full Text] [Related]
3. Rapid assay of topiramate in dried blood spots by a new liquid chromatography-tandem mass spectrometric method.
la Marca G; Malvagia S; Filippi L; Fiorini P; Innocenti M; Luceri F; Pieraccini G; Moneti G; Francese S; Dani FR; Guerrini R
J Pharm Biomed Anal; 2008 Dec; 48(5):1392-6. PubMed ID: 18980824
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic monitoring of topiramate: evaluation of the saturable distribution between erythrocytes and plasma of whole blood using an optimized high-pressure liquid chromatography method.
Gidal BE; Lensmeyer GL
Ther Drug Monit; 1999 Oct; 21(5):567-76. PubMed ID: 10519457
[TBL] [Abstract][Full Text] [Related]
5. Rapid gas chromatographic procedure for the determination of topiramate in serum.
Wolf CE; Crooks CR; Poklis A
J Anal Toxicol; 2000 Oct; 24(7):661-3. PubMed ID: 11043677
[TBL] [Abstract][Full Text] [Related]
6. Analysis of topiramate and its metabolites in plasma and urine of healthy subjects and patients with epilepsy by use of a novel liquid chromatography-mass spectrometry assay.
Britzi M; Soback S; Isoherranen N; Levy RH; Perucca E; Doose DR; Maryanoff BE; Bialer M
Ther Drug Monit; 2003 Jun; 25(3):314-22. PubMed ID: 12766560
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic drug monitoring of topiramate by liquid chromatography-tandem mass spectrometry.
Matar KM
Clin Chim Acta; 2010 May; 411(9-10):729-34. PubMed ID: 20138857
[TBL] [Abstract][Full Text] [Related]
8. Comparison of a new serum topiramate immunoassay to fluorescence polarization immunoassay.
Snozek CL; Rollins LA; Peterson PW; Langman LJ
Ther Drug Monit; 2010 Feb; 32(1):107-11. PubMed ID: 20010458
[TBL] [Abstract][Full Text] [Related]
9. Liquid chromatography tandem mass spectrometry assay for topiramate analysis in plasma and cerebrospinal fluid: validation and comparison with fluorescence-polarization immunoassay.
Christensen J; Højskov CS; Poulsen JH
Ther Drug Monit; 2002 Oct; 24(5):658-64. PubMed ID: 12352939
[TBL] [Abstract][Full Text] [Related]
10. Assay of residual organic solvents in topiramate drug substance by capillary gas chromatography.
Micheel AP; Ko CY; Evans CR
J Pharm Biomed Anal; 1993; 11(11-12):1233-8. PubMed ID: 8123739
[TBL] [Abstract][Full Text] [Related]
11. Simple and rapid liquid chromatographic-turbo ion spray mass spectrometric determination of topiramate in human plasma.
Contin M; Riva R; Albani F; Baruzzi A
J Chromatogr B Biomed Sci Appl; 2001 Sep; 761(1):133-7. PubMed ID: 11585128
[TBL] [Abstract][Full Text] [Related]
12. Comparison of topiramate concentrations in plasma and serum by fluorescence polarization immunoassay.
Berry DJ; Patsalos PN
Ther Drug Monit; 2000 Aug; 22(4):460-4. PubMed ID: 10942188
[TBL] [Abstract][Full Text] [Related]
13. Topiramate: a review of analytical approaches for biological matrices.
Pinto EC; Dolzan MD; Cabral LM; Armstrong DW; de Sousa VP
Biomed Chromatogr; 2015 Oct; 29(10):1461-72. PubMed ID: 25873016
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a reference measurement procedure for certification of phenytoin, phenobarbital, lamotrigine, and topiramate in human serum using isotope-dilution liquid chromatography/tandem mass spectrometry.
Tai SS; Yeh CY; Phinney KW
Anal Bioanal Chem; 2011 Oct; 401(6):1915-22. PubMed ID: 21874530
[TBL] [Abstract][Full Text] [Related]
15. Topiramate pharmacokinetics in infants.
Glauser TA; Miles MV; Tang P; Clark P; McGee K; Doose DR
Epilepsia; 1999 Jun; 40(6):788-91. PubMed ID: 10368080
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of topiramate during pregnancy.
Ohman I; Sabers A; de Flon P; Luef G; Tomson T
Epilepsy Res; 2009 Dec; 87(2-3):124-9. PubMed ID: 19740626
[TBL] [Abstract][Full Text] [Related]
17. Development of a fluorescence polarization immunoassay for lorazepam quantification.
Agbuya PG; Li L; Miles MV; Zaritsky AL; Morris AD
Ther Drug Monit; 1996 Apr; 18(2):194-9. PubMed ID: 8721284
[TBL] [Abstract][Full Text] [Related]
18. Determination of ifosfamide, 2- and 3-dechloroethyifosfamide using gas chromatography with nitrogen-phosphorus or mass spectrometry detection.
Kerbusch T; Jeuken MJ; Derraz J; van Putten JW; Huitema AD; Beijnen JH
Ther Drug Monit; 2000 Oct; 22(5):613-20. PubMed ID: 11034269
[TBL] [Abstract][Full Text] [Related]
19. Topiramate kinetics during delivery, lactation, and in the neonate: preliminary observations.
Ohman I; Vitols S; Luef G; Söderfeldt B; Tomson T
Epilepsia; 2002 Oct; 43(10):1157-60. PubMed ID: 12366729
[TBL] [Abstract][Full Text] [Related]
20. Simple and sensitive high performance liquid chromatography method with fluorescence detection for therapeutic drug monitoring of topiramate.
Milosheska D; Vovk T; Grabnar I; Roškar R
Acta Chim Slov; 2015; 62(2):411-9. PubMed ID: 26085425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
